Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090

Scott Evans, Tzu-min Yeh, Ned Sacktor, David B. Clifford, David M. Simpson, Eric N. Miller, Ronald J. Ellis, Victor G. Valcour, Christina M. Marra, Linda L. Millar, Giovanni Schifitto. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007. 8: 437-46.

Year

2007

Journal

HIV Clinical Trials

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application

Kim Keil, Jill S. Hochreiter, Robin DiFrancesco, Barry Zingman, Richard C. Reichman, Margaret A. Fischl, Barbara Gripshover, Gene D. Morse. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic Drug Monitoring. 2007. 29: 103-9.

Year

2007

Journal

Therapeutic Drug Monitoring

Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers

Qing Ma, Alan Forrest, Susan L Rosenkranz, Michael F. Para, Kevin E. Yarasheski, Richard C. Reichman, Gene D. Morse. Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharmaceutics & Drug Disposition. 2007. 29: 91-101.

Year

2007

Journal

Biopharmaceutics & Drug Disposition

A truvada hypersensitivity reaction simulating abacavir hypersensitivity

Peter T. Frame, Carl J. Fichtenbaum. A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS. 2007. 21: 2252-3.

Year

2007

Journal

AIDS

The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]

Minhee Kang, Raymond T. Chung. The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]. Journal of Acquired Immune Deficiency Syndromes. 2007. 46: 371-3.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

Nonparametric estimation of the mean function of a stochastic process with missing observations

Joan X. Hu, Stephen W. Lagakos. Nonparametric estimation of the mean function of a stochastic process with missing observations. Lifetime Data Analysis. 2007. 13: 51-73.

Year

2007

Journal

Lifetime Data Analysis

Statistics in medicine--reporting of subgroup analyses in clinical trials

Rui Wang, Stephen W. Lagakos, J. H. Ware, Deborah L. Hunter, J. Drazen. Statistics in medicine--reporting of subgroup analyses in clinical trials. New England Journal of Medicine. 2007. 357: 2189-94.

Year

2007

Journal

New England Journal of Medicine

Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania

Habib O. Ramadhani, Nathan Thielman, Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, Humphrey J. Shao, Susan C. Morpeth, Jonathan D. McNeill, John F. Shao, John Alexander Bartlett, John A. Crump. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases. 2007. 45: 1492-8.

Year

2007

Journal

Clinical Infectious Diseases

Antiretroviral therapy for HIV-1-infected children in Haiti

Erik George, Francine Noel, Rose May Gyrlande Bois, Rachelle Cassagnol, Louise Estavien, Patricia De Matteis Rouzier, Rose I. Verdier, Warren D. Johnson, Jean William Pape, Daniel W. Fitzgerald, Peter Farnum Wright. Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases. 2007. 195: 1411-8.

Year

2007

Journal

Journal of Infectious Diseases

Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2

Nicholas T. Funderburg, Michael M. Lederman, Zhimin Feng, Michael G. Drage, Julie Jadlowsky, Clifford V. Harding, Scott F. Sieg. Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America. 2007. 104: 18631-5.

Year

2007

Journal

Proceedings of the National Academy of Sciences of the United States of America